Table 2.
CSVD imaging markers | Gait speed |
Chair-stand |
||
---|---|---|---|---|
β (SE) | p | β (SE) | p | |
Total WMH | ||||
Model 1 | -0.106 (0.040) | 0.007* | 0.157 (0.038) | <0.0001** |
Model 2 | -0.098 (0.040) | 0.014* | 0.150 (0.038) | 0.0001** |
Model 3 | -0.092 (0.040) | 0.022* | 0.153 (0.039) | <0.0001** |
PVWMH | ||||
Model 1 | -0.096 (0.040) | 0.016* | 0.183 (0.038) | <0.0001** |
Model 2 | -0.087 (0.040) | 0.029* | 0.176 (0.038) | <0.0001** |
Model 3 | -0.080 (0.040) | 0.047* | 0.180 (0.039) | <0.0001** |
DWMH | ||||
Model 1 | -0.076 (0.038) | 0.045* | 0.102 (0.037) | 0.006** |
Model 2 | -0.069 (0.038) | 0.069 | 0.100 (0.037) | 0.007** |
Model 3 | -0.066 (0.038) | 0.083 | 0.101 (0.037) | 0.006** |
Lacunes | ||||
Model 1 | -0.061 (0.038) | 0.110 | 0.061 (0.037) | 0.101 |
Model 2 | -0.058 (0.038) | 0.130 | 0.062 (0.037) | 0.096 |
Model 3 | -0.047 (0.039) | 0.229 | 0.067 (0.038) | 0.080 |
CMBs | ||||
Model 1 | 0.008 (0.036) | 0.826 | 0.057 (0.036) | 0.107 |
Model 2 | 0.006 (0.037) | 0.869 | 0.070 (0.036) | 0.052 |
Model 3 | 0.009 (0.037) | 0.806 | 0.069 (0.036) | 0.058 |
PVS-WM | ||||
Model 1 | -0.026 (0.037) | 0.477 | 0.005 (0.036) | 0.896 |
Model 2 | -0.029 (0.036) | 0.420 | 0.004 (0.036) | 0.901 |
Model 3 | -0.027 (0.037) | 0.457 | 0.007 (0.036) | 0.853 |
PVS-BG | ||||
Model 1 | -0.041 (0.036) | 0.257 | -0.018 (0.036) | 0.605 |
Model 2 | -0.044 (0.036) | 0.228 | -0.020 (0.036) | 0.582 |
Model 3 | -0.049 (0.037) | 0.182 | -0.022 (0.036) | 0.549 |
BPF | ||||
Model 1 | 0.065 (0.051) | 0.204 | -0.081 (0.050) | 0.108 |
Model 2 | 0.056 (0.051) | 0.273 | -0.068 (0.050) | 0.171 |
Model 3 | 0.061 (0.052) | 0.238 | -0.067 (0.050) | 0.186 |
β, standardized β coefficient; CSVD, cerebral small vessel disease; WMH, white matter hyperintensities; CMBs, cerebral microbleeds; PVS-WM, dilated perivascular spaces in white matter; PVS-BG, dilated perivascular spaces in BG; BPF, brain parenchymal fraction. Model 1: adjustment for age, sex, and height. Model 2: additional adjustment for MMSE, education level (high school and above vs. below). Model 3: additional adjustment for vascular risk factors (hypertension, DM, hyperlipidemia, and smoking status). ∗Uncorrected p < 0.05.∗∗Surviving a false discovery rate (FDR)-corrected threshold of p(FDR) = 0.05.